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Abstract Treacher Collins syndrome (TCS) is associated
with an abnormal differentiation of the first and second
pharyngeal arches during fetal development. This causes
mostly craniofacial deformities, which require numerous
corrective surgeries. TCS is an autosomal dominant disorder
and it occurs in the general population at a frequency of 1 in
50,000 live births. The syndrome is caused by mutations in
the TCOF1 gene, which encodes the serine/alanine-rich
protein named Treacle. Over 120 mutations of the TCOF1
gene responsible for TCS have been described. About 70%
of recognized mutations are deletions, which lead to a frame
shift, formation of a termination codon, and shortening of
the protein product of the gene. Herewith, a new heterozy-
gotic insertion, c.484_668ins185bp, was described in two
monozygotic twin sisters suffering from TCS. This mutation
was absent in their father, brother, and uncle, indicating a de
novo origin. The insertion causes a shift in the reading frame
and premature termination of translation at 167 aa. The
novel insertion is the longest ever found in the TCOF1 gene
and the only one found among monozygotic twin sisters.
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Treacher Collins syndrome (TCS) [Online Mendelian
Inheritance in Man (OMIM) 154500; http://www.omim.org/
entry/154500], also referred to as Franceschetti syndrome, is
an autosomal dominant disorder affecting differentiation of
the first and second pharyngeal arches, and is classified as a
mandibulofacial dysostosis (MFD1) (Metro 1965). It occurs
in the general population at a frequency of 1 in 50,000 live
births. In 60% of cases, the syndrome is caused by de novo
mutations, while in the other 40%, it has a family history
(Jones et al. 1975).
Abnormal differentiation of the pharyngeal arches in
TCS is caused mainly by mutations in the TCOF1 gene
(Treacher Collins-Franceschetti 1). The gene is comprised
of 25 exons, 49 to 561 bp in length. In 2004, So et al. (2004)
discovered two additional exons: 6A of length 231 bp,
situated between exons 6 and 7, and 16A, 108 bp in length,
localized between exons 16 and 17.
The TCOF1 gene transcript encodes a protein named
Treacle, consisting of 1411aa (Valdez et al. 2004), while
the transcript containing the additional exon 6A encodes a
protein which is longer by 77aa (So et al. 2004). Treacle
participates in the formation of pre-rRNA by interacting
with UBF (upstream binding factor) and binding to the
UCE (upstream control element) sequence, as well as to
the main promoter region, causing DNA looping during
the transcription process (Valdez et al. 2004).
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However, in some patients with TCS, no mutations in the
TCOF1 gene were found. In these individuals, mutations in
the POLR1C and POLR1D genes encoding a subunit of
RNA polymerases I and III have recently been detected
(Dauwerse et al. 2011), suggesting that TCS is genetically
heterogeneous and results from a defect in ribosome
biogenesis.
TCS is attributed to haploinsufficiency or a negative
dominant effect of the mutated protein. Over 120 mutations
of the TCOF1 gene, responsible for TCS, have been
described so far (Gladwin et al. 1996; Wise et al. 1997;
Splendore et al. 2000; Ellis et al. 2002; Marszałek et al.
2003; Dixon et al. 2004; Su et al. 2006). It has been
shown that the reported diversity of patients’ phenotypes
does not depend on the type and localization of the
mutation (Splendore et al. 2000).
This report describes clinical findings, molecular diag-
nostics, and treatment of monozygotic twin sisters with
typical symptoms of TCS, operated upon at the Department
of Plastic Surgery of Wrocław Medical University, Poland.
The research described was reviewed and approved by the
relevant bioethical committee.
Twin sisters, 18 years of age at the time of analysis, were
born at full term from young, healthy, unrelated parents who
did not show any apparent craniofacial abnormalities.
Clinical symptoms were identical in both sisters and included
downward slanting of the eyelids (anti-mongolian slant),
hypoplasia of the zygomatic bone, mandibular hypoplasia,
coloboma with eyelashes absent in the medial part of the
eyelids, microtia (underdevelopment of the auricles), and
hypoplasia of the middle ear with concomitant atresia of the
external auditory canal. On the basis of clinical symptoms,
TCS was diagnosed. Both sisters underwent several opera-
tions, including reconstruction of the ears, reconstruction of
the zygomatic bone and lateral margins of the orbits
using spongy iliac bone grafts, eyelid correction by means
of Z-plasty and long musculocutaneous flap transpositions
from the upper lids, rhinoplasty, and chin osteotomy using
Obwegeser’s method (Fig. 1c–f).
DNA was isolated from peripheral blood leukocytes of
the two patients and their healthy brother, father, and uncle.
We were unable to obtain genetic material from the patients’
mother because she had died before the time of sampling.
Exons 1 through 27 of TCOF1, including exon–intron bor-
ders, were amplified by polymerase chain reaction (PCR)
under optimal conditions, using specific primers. The PCR
products were subjected to multitemperature single-strand
conformation polymorphism (MSSCP) analysis in 8%
polyacrylamide gel at 5°C, 15°C, and 25°C, using the
DNAPointerMutationDetection System. The electrophoresis
was followed by silver staining.
Fragments of the allele which exhibited an abnormal
MSSCP pattern were separated from the normal allele by
electrophoresis in 8% polyacrylamide gel. The fragments
Fig. 1 Electrophoretic analysis of DNA and photographs of monozy-
gotic twin sisters with Treacher Collins syndrome (TCS). a Multi-
temperature single-strand conformation polymorphism (MSSCP)
analysis of the amplified exon 5 of TCOF1. The arrow indicates
samples which demonstrate changes in the electrophoretic mobility
of single-stranded and double-stranded DNA fragments. b
Electrophoretic separation of the amplified fragment of exon 5 in 8%
polyacrylamide gel. Lanes 1 and 2, patients; 3, patients’ brother; 4,
patients’ father; 5, patients’ uncle; C, healthy subject;M, size marker. c
Patient 1: preoperative view at 13 years of age. d Patient 2: preoper-
ative view at 13 years of age. e Patient 1: postoperative view at 16 years
of age. f Patient 2: postoperative view at 16 years of age
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removed from the gel were eluted in 1× TAE buffer at 75°C
for 2 h. After elution, the fragments were used as templates
for the reamplification of single bands by PCR. The PCR
products were purified on the DNA Gel Out columns (A&A
Biotechnology, Poland), followed by direct sequencing with
the use of a BigDye v3.0 Terminator Cycle Sequencing Kit
and specific primers. The dideoxy-terminated fragments
were identified by capillary gel electrophoresis based on
the ABI 310 DNA Analysis System.
The MSSCP analysis of the amplified fragments of exon
5 of the TCOF1 gene (Fig. 1a) demonstrated changes in the
electrophoretic mobility of the single- and double-stranded
DNA in the two patients, while the changes were observed
in neither in the patients’ father, brother, or uncle, nor in
154 healthy subjects. Electrophoretic separation in 8%
polyacrylamide gel (Fig. 1b) revealed striking differences
in the migration of the amplified fragments. In order to
confirm the results obtained in the MSSCP analysis and
in the separation of 8% polyacrylamide gel, direct sequence
analysis was performed of the normal and mutated allele
fragments.
The analysis on the inserted fragment demonstrated a







Analysis of the novel insertion with the use of the
OMIGA 2.0 system allows an assumption that it causes a
premature termination of translation at 167aa, which results
in the formation of a protein product of the gene devoid of
the nuclear localization signal.
A majority of mutations responsible for TCS are local-
ized in exons, mainly in the hot spots in exons 10, 15, 16,
23, and 24 (Splendore et al. 2000). However, relatively few
mutations were described in exon 5. The most commonly
occurring mutations of the TCOF1 gene include deletions,
from 1 to 40 bp, which cause a shift of the reading frame,
formation of the termination codon, and shortening of the
protein product devoid of the nuclear localization signal.
The next most common mutations of the TCOF1 gene are
insertions, most frequently localized in exons 9, 10, and 23.
In the investigated patients, a novel, heterozygotic inser-
tion, c.484_668ins185bp, was detected in two monozygotic
twin sisters. This mutation was absent in the patients’ father,
brother, and uncle, which probably indicates a de novo
origin, since the examination of the patients’ mother was
not possible. The c.484_668ins185bp insertion causes a
reading-frame shift and premature termination of translation
at 167aa. The novel c.484_668ins is the longest (185-bp)
insertion discovered in the TCOF1 gene.
We believe that these findings facilitated a precise diag-
nosis of both patients and extended our knowledge of the
pathogenesis of TCS.
Molecular diagnostics play a significant role for
patients with TCS, in both the prenatal and postnatal
stages, and has an undeniable impact on the develop-
ment of genetic counseling. Molecular evaluation is of
extreme importance for families with a history of TCS,
including both examined sisters, to determine the risk of
the disease in their offspring. Presently, the prenatal
diagnostics of TCS is carried out by means of fetoscopy
or ultrasound evaluation (Cohen et al. 1995). Although
non-invasive ultrasound techniques have progressed re-
cently, the diagnosis of TCS intra-utero is very difficult
and mild TCS cases may remain undiagnosed. On the
other hand, molecular examinations may be performed
in the first trimester and provide an accurate diagnosis.
This type of diagnostics may be conducted in cases
such as the twin sisters examined in this paper.
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